MGI phenotypes (allele matching)
- prenatal lethality, complete penetrance / MGI
B6.129P2-Rbm39Gt(U3Betageo)1Ruiz/Cnrm
| Status | Available to order |
| EMMA ID | EM:01515 |
| Citation information | RRID:IMSR_EM:01515 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
| International strain name | B6.129P2-Rbm39Gt(U3Betageo)1Ruiz/Cnrm |
| Alternative name | M016E07 |
| Strain type | Gene-trap |
| Allele/Transgene symbol | Rbm39Gt(U3Betageo)1Ruiz |
| Gene/Transgene symbol | Rbm39 |
Information from provider
| Provider | Harald von Melchner |
| Provider affiliation | University of Frankfurt Medical School |
| Genetic information | Disruption of exon 1 of the Rbm39 (Rnpc2) gene by the U3bgeo retroviral gene trap vector. |
| Phenotypic information | Embryonic lethality before E8.5. |
| Breeding history | Backcrossed over 5 generations. |
| References |
|
Information from EMMA
| Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
MGI phenotypes (gene matching)
- prenatal lethality, complete penetrance / MGI
Literature references
- A large-scale, gene-driven mutagenesis approach for the functional analysis of the mouse genome.;Hansen Jens, Floss Thomas, Van Sloun Petra, Füchtbauer Ernst-Martin, Vauti Franz, Arnold Hans-Hennig, Schnütgen Frank, Wurst Wolfgang, von Melchner Harald, Ruiz Patricia, ;2003;Proceedings of the National Academy of Sciences of the United States of America;100;9918-22; 12904583
- Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors.;Jung Dong-Ju, Na Soon-Young, Na Doe Sun, Lee Jae Woon, ;2002;The Journal of biological chemistry;277;1229-34; 11704680
- Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.;Imai H, Chan E K, Kiyosawa K, Fu X D, Tan E M, ;1993;The Journal of clinical investigation;92;2419-26; 8227358